Recommendation on how to switch between different anticoagulant regimens | Download Table
Switching of antithrombotic therapy | STROKE MANUAL
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population - ScienceDirect
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
Practical application of anticoagulation therapy af and vte april 12 | PPT
The Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia
Frontiers | Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
CorConsult Rx - #Repost @ambcarerx ・・・ Oral Anticoagulants have many chronic indications, most commonly VTE treatment/prophylaxis, atrial fibrillation, and valvular heart disease. VTE & AF can both be treated with either warfarin
Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study | BMC Primary Care | Full Text
Initiate or switch to ELIQUIS® (apixaban) | ELIQUIS IRELAND
APIXABAN Drug Profile Flashcards | Quizlet
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Switching from warfarin to NOAC. NOAC, non-vitamin K antagonist oral... | Download Scientific Diagram
The Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia
Apixaban (Eliquis): could it take the job of Warfarin?
The Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia
Warfarin to DOAC and DOAC to Warfarin Transitions Here ... | GrepMed
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis - ScienceDirect
Replacing warfarin with a NOAC in patients on chronic anticoagulation therapy - The Hospitalist
Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences | Advances in Therapy
